1900 Wealth Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.66M Sell
6,582
-14
-0.2% -$3.01K 0.09% 93
2026
Q1
$1.43M Sell
6,596
-774
-11% -$172K 0.09% 88
2025
Q4
$1.68M Buy
7,370
+2,365
+47% +$539K 0.11% 84
2025
Q3
$1.16M Buy
5,005
+1,651
+49% +$336K 0.08% 95
2025
Q2
$623K Sell
3,354
-385
-10% -$71.6K 0.05% 119
2025
Q1
$783K Buy
3,739
+184
+5% +$35.8K 0.07% 104
2024
Q4
$632K Buy
3,555
+2
+0.1% +$368 0.05% 118
2024
Q3
$702K Buy
3,553
+644
+22% +$120K 0.06% 117
2024
Q2
$499K Buy
2,909
+2
+0.1% +$331 0.05% 144
2024
Q1
$529K Sell
2,907
-2,830
-49% -$488K 0.05% 150
2023
Q4
$889K Sell
5,737
-510
-8% -$74.4K 0.08% 149
2023
Q3
$931K Buy
6,247
+3,303
+112% +$485K 0.09% 141
2023
Q2
$397K Buy
2,944
+313
+12% +$45.9K 0.04% 174
2023
Q1
$423K Hold
2,631
0.05% 170
2022
Q4
$425K Buy
2,631
+71
+3% +$10.9K 0.05% 168
2022
Q3
$343K Buy
2,560
+352
+16% +$50.5K 0.04% 172
2022
Q2
$339K Buy
2,208
+674
+44% +$103K 0.04% 184
2022
Q1
$249K Buy
1,534
+2
+0.1% +$291 0.02% 221
2021
Q4
$207K Buy
+1,532
New +$181K 0.02% 234

Other funds holding ABBV

1900 Wealth Management's ABBV Position: Q2 2026 in Review

1900 Wealth Management reduced its AbbVie (ABBV) stake by 0.21% in Q2 2026, selling an estimated $3.01K and leaving 6,582 shares worth $1.66M. The position accounts for 0.09% of the portfolio, ranked #93.

1900 Wealth Management first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.68M in Q4 2025. 4,206 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • 1900 Wealth Management held 6,582 shares of AbbVie worth $1.66M as of Q2 2026.
  • 1900 Wealth Management sold 14 AbbVie shares in Q2 2026, an estimated $3.01K.
  • AbbVie made up 0.09% of 1900 Wealth Management's portfolio in Q2 2026, its #93 holding.
  • 1900 Wealth Management first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
  • 1900 Wealth Management's AbbVie position peaked at $1.68M in Q4 2025.
  • 4,206 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on 1900 Wealth Management's 13F filing for Q2 2026, filed 4 Aug 2026.